The current institutional shareholding score of Inovio Pharmaceuticals Inc is 3.00, ranking 193 out of 389 in the Biotechnology & Medical Research industry. The latest institutional shareholding proportion is 40.31%, representing a quarter-over-quarter increase of 9.34%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.93% of shares outstanding, with 18.85% increase in holdings.